Age-specific effectiveness of the Finnish cervical cancer screening programme

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 8, 2012, Pages 1354-1361

  Lönnberg, Stefan ^a   Anttila, Ahti ^a   Luostarinen, Tapio ^a   Nieminen, Pekka ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; FINLAND; GROUPS BY AGE; HUMAN; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERUS CARCINOMA; WART VIRUS;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FINLAND; HUMANS; MIDDLE AGED; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84864826020     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0162     Document Type: Article

References (25)

1. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al., editors. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Luxembourg, Europe: Office for Official Publications of the European Communities; 2008.
2. Verbeek AL, Broeders MJ. Evaluation of cancer service screening: case referent studies recommended. Stat Methods Med Res 2010;19:487-505.
3. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva (online). Current Care Guideline. Working group set up by the Finnish Medical Society Duodecim and the Finnish Colposcopy Association. Helsinki, Finland: Finnish Medical Society Duodecim; 2010 [cited 2012 Feb 7]. Available from: http://www.kaypahoito.fi.
4. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009;101:1612-23.
5. Anttila A, Hakama M, Kotaniemi-Talonen L, Nieminen P. Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Public Health 2006;6:252.
6. Lönnberg S, Leinonen M, Malila N, Anttila A. Validation of histological diagnoses in a national cervical screening register. Acta Oncol 2012;51:37-44.
7. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4.
8. Finnish Cancer Registry. Cancer in Finland 2008 and 2009. Cancer Society of Finland Publication No. 84, Helsinki, 2011.
9. Duffy SW, Cuzick J, Tabar L, Vitak B, Chen TH-H, Yen M-F, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Stat Soc Ser C Appl Stat 2002;51:235-43.
10. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9.
11. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009;339:b2968.
12. Andrae B, Strander B, Silfverdal L, Ryd W, Dillner J, Törnberg S, et al. Bene fit of cervical cancer screening in young women-a matter of adherence to the recommended screening interval [Rapid Response]. London, United Kingdom: BMJ; 2009 [updated 2009 Aug 1; cited 2012 Mar 22]. Available from: http://www.bmj.com/rapid-response/2011/11/02/benefit-cervical-cancer-screening- young-women-matter-adherence-recommended.
13. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93. (Pubitemid 36897941)
14. Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer 2004;90:1784-6. (Pubitemid 38725653)
15. Terveyden ja hyvinvoinnin laitos. Terveyden ja hyvinvoinnin laitoksen asettaman papilloomavirustautien torjuntatyöryhmän selvitys [Report of the study by the Expert Group on Papillomavirus Disease Prevention appointed by the National Institute for Health and Welfare]. THL Report 28/2011. [cited 2012 Feb 7]. Available from: http://www.thl.fi/thl-client/pdfs/94d6f45d-22e1-4b53- b615-2eea48d90e1c.
16. Nieminen P, Kallio M, Anttila A, Hakama M. Organised vs. spontaneous papa-smear screening for cervical cancer: a case-control study. Int J Cancer 1999;83:55-8. (Pubitemid 29409477)
17. Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009;9:119.
18. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8. (Pubitemid 29090994)
19. Weiss NS. Case-control studies of the ef ficacy of screening tests designed to prevent the incidence of cancer. Am J Epidemiol 1999;149:1-4. (Pubitemid 29028855)
20. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw 1968;75:392-404.
21. Hakama M, Räsänen-Virtanen U. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976;103:512-7.
22. Magnus K, Langmark F, Andersen A. Mass screening for cervical cancer in Ostfold county of Norway 1959-77. Int J Cancer 1987;39:311-6. (Pubitemid 17038185)
23. Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.
24. Schopper D, de Wolf C. How effective are breast cancer screening programmes bymammography? Review of the current evidence. Eur J Cancer 2009;45:1916-23.
25. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9.